Free Trial

Titan Medical (TMDIF) Competitors

Titan Medical logo
$0.50 0.00 (0.00%)
As of 02/20/2025

TMDIF vs. DRTS, CATX, KRMD, NVRO, OBIO, BWAY, SKIN, PROF, INFU, and TLSI

Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Alpha Tau Medical (DRTS), Perspective Therapeutics (CATX), KORU Medical Systems (KRMD), Nevro (NVRO), Orchestra BioMed (OBIO), BrainsWay (BWAY), Beauty Health (SKIN), Profound Medical (PROF), InfuSystem (INFU), and TriSalus Life Sciences (TLSI). These companies are all part of the "medical equipment" industry.

Titan Medical vs.

Alpha Tau Medical (NASDAQ:DRTS) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment.

Alpha Tau Medical received 19 more outperform votes than Titan Medical when rated by MarketBeat users.

CompanyUnderperformOutperform
Alpha Tau MedicalOutperform Votes
19
70.37%
Underperform Votes
8
29.63%
Titan MedicalN/AN/A

Alpha Tau Medical has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.

In the previous week, Alpha Tau Medical had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for Titan Medical. Alpha Tau Medical's average media sentiment score of 1.35 beat Titan Medical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Positive
Titan Medical Neutral

Alpha Tau Medical presently has a consensus target price of $8.00, indicating a potential upside of 198.51%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Alpha Tau Medical is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Alpha Tau Medical's return on equity of -38.62% beat Titan Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -38.62% -29.89%
Titan Medical N/A -82.31%-51.47%

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Titan Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$29.16M-$0.43-6.23
Titan Medical$17.63M3.23$6.95M$0.0510.00

Summary

Alpha Tau Medical beats Titan Medical on 10 of the 14 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDIF vs. The Competition

MetricTitan MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$57.02M$4.69B$5.82B$9.09B
Dividend YieldN/A39.91%4.77%3.84%
P/E Ratio-0.4018.4218.9215.38
Price / Sales3.2350.81453.2984.08
Price / Cash0.0251.1543.8437.22
Price / Book0.486.577.644.65
Net Income$6.95M$90.13M$3.18B$245.69M
7 Day Performance42.45%-2.20%-1.95%-2.67%
1 Month Performance-1.96%-2.17%-0.23%-2.16%
1 Year PerformanceN/A15.26%16.69%12.90%

Titan Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDIF
Titan Medical
N/A$0.50
flat
N/A+646.3%$57.02M$17.63M-0.4050
DRTS
Alpha Tau Medical
2.9255 of 5 stars
$3.12
+0.2%
$8.00
+156.8%
-12.1%$217.80MN/A-7.2480Positive News
Gap Up
CATX
Perspective Therapeutics
1.6313 of 5 stars
$3.20
-1.4%
$15.14
+374.0%
N/A$215.95M$1.43M0.0070Gap Up
KRMD
KORU Medical Systems
3.1528 of 5 stars
$4.71
+1.2%
$4.50
-4.4%
+79.2%$215.91M$28.52M-18.8480
NVRO
Nevro
1.8895 of 5 stars
$5.72
-0.1%
$6.43
+12.4%
-65.3%$214.14M$425.17M-3.021,215Analyst Forecast
OBIO
Orchestra BioMed
2.738 of 5 stars
$5.52
-1.2%
$16.25
+194.7%
-18.3%$209.28M$2.76M-3.424
BWAY
BrainsWay
2.4423 of 5 stars
$10.73
-0.1%
$13.17
+22.8%
+70.1%$201.84M$31.78M107.26120Gap Up
SKIN
Beauty Health
1.6565 of 5 stars
$1.62
-0.3%
$2.55
+57.9%
-42.5%$200.45M$398M-3.851,030
PROF
Profound Medical
3.1718 of 5 stars
$5.80
-0.9%
$14.25
+145.7%
-9.3%$174.26M$7.20M-4.33150Analyst Revision
News Coverage
Positive News
INFU
InfuSystem
N/A$8.08
-0.4%
$13.00
+60.8%
N/A$171.67M$125.79M134.61410High Trading Volume
TLSI
TriSalus Life Sciences
3.8907 of 5 stars
$5.56
-0.4%
$11.79
+112.0%
-36.3%$169.31M$18.51M-2.23106

Related Companies and Tools


This page (NASDAQ:TMDIF) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners